Travere Therapeutics, Inc. · NASDAQ:TVTX

Macquarie Group LTD reported a 4.90% stake in Travere Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 7, 2025

Macquarie Group LTD reported a 4.90% stake in Travere Therapeutics, Inc., 4,259,557 shares, as a passive investor on Dec 31, 2024. Filed Feb 7, 2025 (Schedule 13G/A).

Stake
4.90%
Shares
4,259,557
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Macquarie Group Limited4.90%4,259,557
Macquarie Management Holdings Inc4.90%4,259,557
Macquarie Investment Management Business Trust4.90%4,259,557

Source

View original at SEC

Related